Therefore, the classification of type 1 and 2 endometrial cancer, the classification of histological subtypes of thyroid cancer, or the comparisons of distributions of cancer stages or profiles of hormone receptor expression between adenomyosis and adenomyosis-free cohorts was not feasible in the current study. The gene discussed is NR4A1; the disease is thyroid cancer.